Agios Pharmaceuticals (AGIO) P/E US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| P/E | ? | 1.24 | -6.64 | -3.52 | 2.77 | -3.82 | -3.92 | ||
| Changes by years, y/y, % | -114% | -636% | -47% | -179% | -238% | -15.6% | |||
Agios Pharmaceuticals. P/E
Agios Pharmaceuticals. P/E, changes, %
Agios Pharmaceuticals (AGIO) P/E US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| P/E | ? | 2.53 | 2.96 | -5.82 | -3.85 | -4.71 | -3.92 | |
| Changes by years, y/y, % | -154% | -144% | -255% | -238% | -286% | |||
| Changes by quarters, q/q, % | -9% | +17% | -296% | -34% | +22% | |||